A multicentre clinical trial of clomipramine in the treatment of obsessional and phobic disorders in general practice is described. All phobias showed an improvement in situational anxiety, interference and autonomic side effects. With the exception of two cases of animal phobia there was also improvement in general anxiety and avoidance. Obsessional cases showed an overall improvement in all symptom areas.
Get full access to this article
View all access options for this article.
References
1.
CapstickN. (1971). Chlorimipramine in obsessional states. Psychosomatics, 12 (5, 332.
2.
CooperJ. (1970). The Leyton Obsessional Inventory. Psychological Medicine, 1, 48.
3.
CordobaE. F.Lopez-IborJ. J. (1967). Monochlorimipramine in the treatment of psychiatric patients resistant to other techniques. Actas Luso españolas de neurología y psiquiatrica, 26, 119.
4.
MarshallW. K. (1971). Treatment of obsessional illnesses and phobic anxiety states with chlomipramine. British Journal of Psychiatry, 119, 467.
5.
Office of Population Censuses and Surveys (1970). Classification of occupations, London. Her Majesty's Stationery Office.
6.
RackP. H. (1973). Clomipramine (Anafranil) in the treatment of obsessional states with special reference to the Leyton Obsessional Inventory. Journal of International Medical Research, 1, 397.
7.
WaxmanD. (1973). A general practitioner investigation on the use of clomipramine (Anafranil) in obsessional and phobic disorders. Journal of International Medical Research, 1, 417.
8.
WolpeJ. (1958). Psychotherapy by reciprocal inhibition. Stanford University Press, Stanford, California.
